You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上海凱寶(300039.SZ)股價異動:痰熱清注射液被列入多省市新冠防治/診療方案
格隆匯 02-04 08:42

格隆匯2月4日丨上海凱寶(300039.SZ)公佈,公司股票連續兩個交易日(2020年1月23日、2020年2月3日)收盤價格漲幅累計偏離值超過20%。根據《深圳證券交易所交易規則》的有關規定,屬於股票交易異常波動情況。

針對公司股票異常波動,公司通過電話及現場問詢方式,對有關事項進行了核查,具體情況説明如下:

1.公司前期披露的信息不存在需要更正、補充之處;

2.自新型冠狀病毒肺炎疫情發生以來,引起了社會廣泛關注。公司於2020年1月27日被上海市經濟和信息化委員會列為生產應急物資場所;於1月31日向上海市紅十字會、湖北省紅十字會等單位分批捐贈了包括痰熱清系列產品、口腔抑菌噴劑、退熱貼、口罩、防護服等價值200餘萬元的物資。

近期公司主營產品痰熱清注射液,相繼被列入北京、上海、陝西、黑龍江等多個省市發佈的新型冠狀病毒感染的肺炎防治方案/診療方案;被河南省列入新型冠狀病毒感染的肺炎防控工作藥品供應保障清單。

除上述事項外,公司未發現近期公共傳媒報道了可能或已經對公司股票交易價格產生較大影響的未公開重大信息;

3.公司目前經營情況及內外部經營環境未發生重大變化;

4.經核查,公司、控股股東和實際控制人不存在關於本公司的應披露而未披露的重大事項,也不存在處於籌劃階段的重大事項;

5.經核查,公司控股股東、實際控制人在股票異常波動期間不存在買賣公司股票的行為;

6.2020年1月17日,公司披露了《2019年年度業績預告》。根據公司財務部門初步測算,2019年度,公司實現歸屬於上市公司股東的淨利潤23,815.30萬元–27,217.49萬元,同比增長5%-20%。具體財務數據將在公司2019年年度報告中詳細披露。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account